ScholarLens Back to search
1964•New England Journal of MedicineRequires access

Methysergide for Prevention of Headache

John R. Graham

Open publisher page 163 citations

Abstract

IN 1959 Sicuteri1 first reported the effectiveness of methysergide‡ in the prevention of migraine. Since then several investigators have confirmed his findings,2 3 4 5 the drug has been extensively studied, and has appeared on the American market under the name of Sansert.‡ The mechanism whereby methysergide prevents headache is not yet fully determined. There are a number of current theories. One is that the drug is a powerful serotonin antagonist and may act by neutralizing the effects of serotonin either in the blood vessels and tissues or in the central nervous system.1 , 6 , 7 Secondly, it is capable of antagonizing the inflammatory effects of . . .

About this research paper

What this paper is about

IN 1959 Sicuteri1 first reported the effectiveness of methysergide‡ in the prevention of migraine. Since then several investigators have confirmed his findings,2 3 4 5 the drug has been extensively studied, and has appeared on the American market under the name of Sansert.‡ The mechanism whereby methysergide prevents headache is not yet fully determined. There are a number of current theories. One is that the drug is a powerful serotonin antagonist and may act by neutralizing the effects of serotonin either in the blood vessels and tissues or in the central nervous system.1 , 6 , 7 Secondly, it is capable of antagonizing the inflammatory effects of . . .

Why it matters

OpenAlex reports 163 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

IN 1959 Sicuteri1 first reported the effectiveness of methysergide‡ in the prevention of migraine. Since then several investigators have confirmed his findings,2 3 4 5 the drug has been extensively studied, and has appeared on the American market under the name of Sansert.‡ The mechanism whereby methysergide prevents headache is not yet fully determined. There are a number of current theories. One is that the drug is a powerful serotonin antagonist and may act by neutralizing the effects of serotonin either in the blood vessels and tissues or in the central nervous system.1 , 6 , 7 Secondly, it is capable of antagonizing the inflammatory effects of . . .

Key concepts: Methysergide, Medicine, Migraine, Serotonin, Antagonist, Drug, Central nervous system, Headaches

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Methysergide for Prevention of Headache — Research Paper | ScholarLens